151 related articles for article (PubMed ID: 10844134)
1. Desensitisation of 5-HT autoreceptors upon pharmacokinetically monitored chronic treatment with citalopram.
Cremers TI; Spoelstra EN; de Boer P; Bosker FJ; Mørk A; den Boer JA; Westerink BH; Wikström HV
Eur J Pharmacol; 2000 Jun; 397(2-3):351-7. PubMed ID: 10844134
[TBL] [Abstract][Full Text] [Related]
2. Augmentation with a 5-HT(1A), but not a 5-HT(1B) receptor antagonist critically depends on the dose of citalopram.
Cremers TI; de Boer P; Liao Y; Bosker FJ; den Boer JA; Westerink BH; Wikström HV
Eur J Pharmacol; 2000 May; 397(1):63-74. PubMed ID: 10844100
[TBL] [Abstract][Full Text] [Related]
3. Multiple 5-HT(1) autoreceptor subtypes govern serotonin release in dorsal and median raphé nuclei.
Hopwood SE; Stamford JA
Neuropharmacology; 2001 Mar; 40(4):508-19. PubMed ID: 11249960
[TBL] [Abstract][Full Text] [Related]
4. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296
[TBL] [Abstract][Full Text] [Related]
5. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse.
Knobelman DA; Hen R; Blendy JA; Lucki I
J Pharmacol Exp Ther; 2001 Sep; 298(3):1092-100. PubMed ID: 11504806
[TBL] [Abstract][Full Text] [Related]
6. Acute and chronic effects of citalopram on 5-HT1A receptor-labeling by [18F]MPPF and -coupling to receptors-G proteins.
Moulin-Sallanon M; Charnay Y; Ginovart N; Perret P; Lanfumey L; Hamon M; Hen R; Fagret D; Ibáñez V; Millet P
Synapse; 2009 Feb; 63(2):106-16. PubMed ID: 19016488
[TBL] [Abstract][Full Text] [Related]
7. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
van Amsterdam C; Seyfried CA
Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
[TBL] [Abstract][Full Text] [Related]
9. Effects of triiodothyronine and imipramine on basal 5-HT levels and 5-HT(1) autoreceptor activity in rat cortex.
Gur E; Lifschytz T; Lerer B; Newman ME
Eur J Pharmacol; 2002 Dec; 457(1):37-43. PubMed ID: 12460641
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo.
Auerbach SB; Hjorth S
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):597-606. PubMed ID: 9053730
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram.
Stenfors C; Yu H; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):222-32. PubMed ID: 11218075
[TBL] [Abstract][Full Text] [Related]
12. Agonist-induced internalization of serotonin-1a receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors).
Riad M; Watkins KC; Doucet E; Hamon M; Descarries L
J Neurosci; 2001 Nov; 21(21):8378-86. PubMed ID: 11606626
[TBL] [Abstract][Full Text] [Related]
13. Acute and chronic effects of citalopram on postsynaptic 5-hydroxytryptamine(1A) receptor-mediated feedback: a microdialysis study in the amygdala.
Bosker FJ; Cremers TI; Jongsma ME; Westerink BH; Wikström HV; den Boer JA
J Neurochem; 2001 Mar; 76(6):1645-53. PubMed ID: 11259482
[TBL] [Abstract][Full Text] [Related]
14. The 5-HT(1A) receptor agonist, 8-OH-DPAT, attenuates stress-induced anorexia in conjunction with the suppression of hypothalamic serotonin release in rats.
Shimizu N; Hori T; Ogino C; Kawanishi T; Hayashi Y
Brain Res; 2000 Dec; 887(1):178-82. PubMed ID: 11134602
[TBL] [Abstract][Full Text] [Related]
15. Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain: an in vivo microdialysis study.
Gur E; Lerer B; Newman ME
J Neural Transm (Vienna); 1997; 104(8-9):795-804. PubMed ID: 9451712
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of (R)-, (R, S)- and (S)-8-hydroxy-2-(di-n-propylamino)tetralin on hippocampal serotonin release and induction of hypothermia in awake rats.
Yoshitake T; Kehr J
Life Sci; 2004 Apr; 74(23):2865-75. PubMed ID: 15050424
[TBL] [Abstract][Full Text] [Related]
17. Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram.
Invernizzi R; Bramante M; Samanin R
Brain Res; 1995 Oct; 696(1-2):62-6. PubMed ID: 8574685
[TBL] [Abstract][Full Text] [Related]
18. Lack of 5-HT1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis.
Hjorth S; Auerbach SB
Neuropharmacology; 1994; 33(3-4):331-4. PubMed ID: 7984270
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronically administered venlafaxine on 5-HT receptor activity in rat hippocampus and hypothalamus.
Gur E; Dremencov E; Van De Kar LD; Lerer B; Newman ME
Eur J Pharmacol; 2002 Feb; 436(1-2):57-65. PubMed ID: 11834247
[TBL] [Abstract][Full Text] [Related]
20. 5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization.
Froger N; Gardier AM; Moratalla R; Alberti I; Lena I; Boni C; De Felipe C; Rupniak NM; Hunt SP; Jacquot C; Hamon M; Lanfumey L
J Neurosci; 2001 Oct; 21(20):8188-97. PubMed ID: 11588191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
